Review article · 2026 · Open access

Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence

Natalia Zdanowska, Natalia Joanna Machoń, Alicja Frączek, Marta Kasprowicz‐Furmańczyk, Joanna Czerwińśka, Agnieszka Barbara Owczarczyk-Saczonek

Frontiers in Immunology, 17, 1849265 · Published 20 July 2026 · DOI 10.3389/fimmu.2026.1849265

Open PDFView at the publisherCite this paper

In brief

“Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence” is a 2026 review article by Natalia Zdanowska and 5 co-authors, published in Frontiers in Immunology. OpenAlex counts 3 citations as of 18 November 2026, which puts it in the top 4% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Immunology.

Citations
3
Most cited in
2026 (3)
Field-weighted impact
3.38
References
77
Authors
6

Abstract

Background: Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease in which disease flares frequently recur at previously affected anatomical sites. This distinctive clinical pattern suggests the presence of residual inflammation and long-lasting local immune memory that persists beyond apparent clinical remission. Objectives: To synthesize current evidence on the role of tissue-resident memory T (TRM) cells in the pathogenesis, chronicity, and relapse of AD, and to discuss how TRM biology may explain disease recurrence after treatment withdrawal and inform future therapeutic strategies. Methods: Narrative review of experimental, translational, and clinical studies addressing TRM differentiation, persistence, metabolic and epigenetic programming, clonal stability, microenvironmental crosstalk, and treatment-related modulation in AD and related chronic dermatoses. Results: TRM are long-lived, non-circulating T cells retained in the skin through adhesion molecules, survival cytokines, metabolic adaptation, and stable epigenetic programs. In AD, both CD4+ and CD8+ TRM persist in lesional and clinically resolved skin and remain transcriptionally poised for rapid reactivation. Clinical studies consistently demonstrate disease relapse after discontinuation of biologics and JAK inhibitors, supporting the concept that current therapies suppress inflammatory pathways without eliminating pathogenic tissue memory. Emerging data suggest that selected interventions, including modulation of costimulatory pathways and survival signals, may partially influence immune memory and prolong disease control in subsets of patients. Conclusion: TRM constitute a central cellular substrate of residual disease memory in AD and provide a mechanistic explanation for site-specific relapse and treatment resistance. Therapeutic strategies that selectively modulate pathogenic TRM and their supporting microenvironment, while preserving protective barrier immunity, may be required to achieve durable remission.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zdanowska, N., Machoń, N. J., Frączek, A., Kasprowicz‐Furmańczyk, M., Czerwińśka, J., & Owczarczyk-Saczonek, A. B. (2026). Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence. Frontiers in Immunology, 17, 1849265. https://doi.org/10.3389/fimmu.2026.1849265

MLA 9

Zdanowska, Natalia, et al. “Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence.” Frontiers in Immunology, vol. 17, 2026, p. 1849265. https://doi.org/10.3389/fimmu.2026.1849265.

Chicago

Zdanowska, Natalia, Natalia Joanna Machoń, Alicja Frączek, Marta Kasprowicz‐Furmańczyk, Joanna Czerwińśka, and Agnieszka Barbara Owczarczyk-Saczonek. 2026. “Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence.” Frontiers in Immunology 17: 1849265. https://doi.org/10.3389/fimmu.2026.1849265.

Harvard

Zdanowska, N. et al. (2026) ‘Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence’, Frontiers in Immunology, 17, p. 1849265. doi:10.3389/fimmu.2026.1849265.

IEEE

N. Zdanowska, N. J. Machoń, A. Frączek, M. Kasprowicz‐Furmańczyk, J. Czerwińśka, and A. B. Owczarczyk-Saczonek, “Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence,” Frontiers in Immunology, vol. 17, p. 1849265, 2026, doi: 10.3389/fimmu.2026.1849265.

BibTeX

@article{zdanowska2026tissue,
  title     = {{Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence}},
  author    = {Zdanowska, Natalia and Machoń, Natalia Joanna and Frączek, Alicja and Kasprowicz‐Furmańczyk, Marta and Czerwińśka, Joanna and Owczarczyk-Saczonek, Agnieszka Barbara},
  journal   = {Frontiers in Immunology},
  year      = {2026},
  volume    = {17},
  pages     = {1849265},
  doi       = {10.3389/fimmu.2026.1849265},
  url       = {https://doi.org/10.3389/fimmu.2026.1849265}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases

  • atopic dermatitis
  • tissue-resident memory T cells
  • recurrence
  • residual inflammation
  • immunological memory
  • CD4+ T cells
  • CD8+ T cells
  • epigenetic programming

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Zdanowska, N., Machoń, N. J., Frączek, A., Kasprowicz‐Furmańczyk, M., Czerwińśka, J., & Owczarczyk-Saczonek, A. B. (2026). Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence. Frontiers in Immunology, 17, 1849265. https://doi.org/10.3389/fimmu.2026.1849265

How many times has this paper been cited?

3 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Immunology: sign in and open the PDF from this page.

Who wrote this paper?

Natalia Zdanowska, Natalia Joanna Machoń, Alicja Frączek, Marta Kasprowicz‐Furmańczyk, Joanna Czerwińśka, Agnieszka Barbara Owczarczyk-Saczonek.

What is the DOI of this paper?

10.3389/fimmu.2026.1849265, permanently at https://doi.org/10.3389/fimmu.2026.1849265. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.